[ Price : $8.95]
FDA says it is requiring a change in labeling for Eisai/Biogens Alzheimers drug Leqembi to call for an earlier MRI monitoring scan...[ Price : $8.95]
FDA releases the form FDA-483 with six observations from an inspection at the Minneapolis, MN-based IntegraDose Compounding Servic...[ Price : $8.95]
Integra LifeSciences recalls (Class 1) its Extended Tip Applicators due to sterility concerns.[ Price : $8.95]
FDA warns Orlando, FL-based Platinum Biologics that it is illegally marketing unapproved new drugs.[ Price : $8.95]
Amylyx Pharmaceuticals discontinues development of its investigational therapy AMX0035 (sodium phenylbutyrate and taurursodiol) in...[ Price : $8.95]
FDA issues an alert after becoming aware that Abiomed sent a letter to customers recommending that certain automated Impella contr...[ Price : $8.95]
BioXcel Therapeutics plans an early 2026 supplemental NDA submission to expand the label of its agitation treatment Igalmi (BXCL50...[ Price : $8.95]
FDA warns Scottsdale, AZ-based Innate Healthcare Institute that it is illegally marketing adulterated and misbranded stem cell pro...